Neuberger Berman Group
CTSO icon

Neuberger Berman Group’s Cytosorbents Corp CTSO Stock Holding History

Neuberger Berman Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Buy
1,968,691
+285,684
+17% +$151K ﹤0.01% 1635
2026
Q1 		$951K Buy
1,683,007
+57,367
+4% +$39.2K ﹤0.01% 1432
2025
Q4 		$1.04M Buy
1,625,640
+27,642
+2% +$21.3K ﹤0.01% 1381
2025
Q3 		$1.49M Buy
1,597,998
+6,309
+0.4% +$6.21K ﹤0.01% 1239
2025
Q2 		$2.03M Sell
1,591,689
-87,939
-5% -$88.3K ﹤0.01% 1158
2025
Q1 		$1.7M Sell
1,679,628
-2,255
-0.1% -$2.38K ﹤0.01% 1175
2024
Q4 		$1.53M Sell
1,681,883
-99,477
-6% -$97.6K ﹤0.01% 1207
2024
Q3 		$2.67M Buy
1,781,360
+244,846
+16% +$268K ﹤0.01% 1066
2024
Q2 		$1.08M Sell
1,536,514
-376,052
-20% -$326K ﹤0.01% 1254
2024
Q1 		$1.81M Sell
1,912,566
-1,691,032
-47% -$1.65M ﹤0.01% 1139
2023
Q4 		$3.99M Buy
3,603,598
+2,100,902
+140% +$3.12M ﹤0.01% 1107
2023
Q3 		$2.82M Buy
1,502,696
+14,051
+0.9% +$40.3K ﹤0.01% 1010
2023
Q2 		$5.34M Sell
1,488,645
-59,278
-4% -$187K ﹤0.01% 877
2023
Q1 		$5.23M Buy
1,547,923
+18,828
+1% +$56.5K ﹤0.01% 868
2022
Q4 		$2.33M Buy
1,529,095
+49,525
+3% +$73.5K ﹤0.01% 1039
2022
Q3 		$2M Buy
1,479,570
+151,300
+11% +$295K ﹤0.01% 1080
2022
Q2 		$2.92M Buy
1,328,270
+76,458
+6% +$176K ﹤0.01% 1031
2022
Q1 		$3.98M Sell
1,251,812
-4,256
-0.3% -$15.2K ﹤0.01% 1024
2021
Q4 		$5.26M Sell
1,256,068
-4,506
-0.4% -$25.3K ﹤0.01% 964
2021
Q3 		$10.2M Buy
1,260,574
+413,485
+49% +$3.36M 0.01% 803
2021
Q2 		$6.39M Sell
847,089
-16,725
-2% -$141K 0.01% 902
2021
Q1 		$7.47M Sell
863,814
-49,335
-5% -$470K 0.01% 872
2020
Q4 		$7.27M Buy
913,149
+330,555
+57% +$2.77M 0.01% 842
2020
Q3 		$4.64M Buy
+582,594
New +$5.26M 0.01% 873

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Neuberger Berman Group's CTSO Position: Q2 2026 in Review

Neuberger Berman Group increased its Cytosorbents Corp (CTSO) stake by 17% in Q2 2026, buying an estimated $151K and bringing the position to 1,968,691 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

Neuberger Berman Group first reported a position in CTSO in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.2M in Q3 2021. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Neuberger Berman Group held 1,968,691 shares of Cytosorbents Corp worth $741K as of Q2 2026.
  • Neuberger Berman Group bought 285,684 Cytosorbents Corp shares in Q2 2026, an estimated $151K.
  • Cytosorbents Corp made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1635 holding.
  • Neuberger Berman Group first reported a position in Cytosorbents Corp in Q3 2020 and has held it in 24 quarters since.
  • Neuberger Berman Group's Cytosorbents Corp position peaked at $10.2M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.